000 | 01465 a2200397 4500 | ||
---|---|---|---|
005 | 20250514055050.0 | ||
264 | 0 | _c20030214 | |
008 | 200302s 0 0 eng d | ||
022 | _a0887-378X | ||
024 | 7 |
_a10.1111/1468-0009.00027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBar-Shalom, Avital | |
245 | 0 | 0 |
_aPatents and innovation in cancer therapeutics: lessons from CellPro. _h[electronic resource] |
260 |
_bThe Milbank quarterly _c2002 |
||
300 |
_a637-76, iii-iv p. _bdigital |
||
500 | _aPublication Type: Journal Article; Legal Case; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiomedical Research _xeconomics |
650 | 0 | 4 |
_aBiotechnology _xeconomics |
650 | 0 | 4 |
_aCancer Care Facilities _xeconomics |
650 | 0 | 4 |
_aEmbryo Research _xlegislation & jurisprudence |
650 | 0 | 4 | _aFinancing, Government |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntellectual Property |
650 | 0 | 4 | _aLicensure |
650 | 0 | 4 | _aNational Institutes of Health (U.S.) |
650 | 0 | 4 |
_aNeoplasms _xtherapy |
650 | 0 | 4 |
_aPatents as Topic _xlegislation & jurisprudence |
650 | 0 | 4 |
_aResearch Support as Topic _xlegislation & jurisprudence |
650 | 0 | 4 | _aSocial Responsibility |
650 | 0 | 4 | _aStem Cells |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUniversities |
700 | 1 | _aCook-Deegan, Robert | |
773 | 0 |
_tThe Milbank quarterly _gvol. 80 _gno. 4 _gp. 637-76, iii-iv |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/1468-0009.00027 _zAvailable from publisher's website |
999 |
_c12334792 _d12334792 |